Compound Guides — Peptide Research Library
One guide per compound: what the peer-reviewed literature reports, the sequence and molecular weight, storage and reconstitution reference figures, and the current Eppix Labs lot with its certificate. Each guide links to its product page and to the lot’s published certificate, and each product page links back. Nothing here is a statement of what a compound does in humans; it is a summary of what has been published and what has not.
- 21
- articles, cited
- 21
- compounds covered
- Aug 27
- latest update
Browse by Topic
- Pillar 02
COAs & Testing
Reading a certificate, HPLC purity vs measured content, spotting a fake COA, Janoshik verification.
12 articles - Pillar 03
Buying Peptides in Canada
Where to buy, what to check, shipping across Canada, payment, storage on arrival.
3 articles - Pillar 04
Regulation & Compliance
Health Canada and FDA positions, research-use-only status, current primary-source reading.
4 articles - Pillar 05
Comparisons & Lab Practice
Compound-vs-compound comparisons, reconstitution math, aliquoting, cold-chain handling.
16 articles
Start Here
Newest articles →5-Amino-1MQ in Canada: The NNMT Inhibitor That Is Not a Peptide
A small molecule in a peptide catalogue, with a specific enzyme target and a certificate that should look different
Adam Reeves · Research Editor · Updated Aug 27, 2026 · 3 min read · 3 references
- Sourcing Guide
NAD+ in Canada: The Coenzyme, Not a Peptide
Adam Reeves · Aug 24, 2026 · 4 min
- Sourcing Guide
Thymosin Alpha-1 in Canada: The Immune Peptide With Real Approvals Elsewhere
Adam Reeves · Aug 20, 2026 · 3 min
- Sourcing Guide
Epitalon in Canada: The Telomerase Claim, Examined
Adam Reeves · Aug 11, 2026 · 4 min
All Articles
Topic
Sort
21 articles
Compound Guides
19- Sourcing GuideTissue Repair
BPC-157 in Canada: Purity, Batch Certificates and What to Check
The most-searched research peptide in Canada, and the four things worth checking before a vial is ordered
- Sourcing GuideTissue Repair
TB-500 in Canada: The Thymosin β4 Fragment, Tested by Batch
What is actually in a TB-500 vial, why the naming confusion matters commercially, and how to verify a lot
- Sourcing GuideMetabolic & GLP-1
Retatrutide in Canada: The Triple Agonist, and What Is Actually Published
A phase 2 compound with real trial data, no approval anywhere, and a research supply market moving faster than the evidence
- Sourcing GuideMetabolic & GLP-1
Tirzepatide in Canada: Research-Grade, and How It Differs From the Pharmacy Product
The dual agonist with the deepest trial record in its class, and the distinction that matters when you buy it as a research material
- Sourcing GuideMetabolic & GLP-1
Semaglutide in Canada: Research-Grade, Verified by Batch
The most-studied GLP-1 analogue, the difference between a research vial and a prescription product, and what a certificate has to prove
- Sourcing GuideTissue Repair
GHK-Cu in Canada: The Copper Peptide, and Why the Copper Is the Hard Part
A tripeptide-copper complex with a fifty-year literature, and a quality question most certificates do not answer
- Sourcing GuideGrowth Hormone
CJC-1295 and Ipamorelin in Canada: The Blend, and What Each Half Does
Two compounds with different mechanisms sold in one vial, and the certificate problem that creates
- Sourcing GuideMetabolic & GLP-1Longevity
MOTS-c in Canada: The Mitochondrial-Derived Peptide
A 16-residue peptide encoded in mitochondrial DNA, a decade of metabolic literature, and a July 2026 regulatory vote
- Sourcing GuideLongevity
NAD+ in Canada: The Coenzyme, Not a Peptide
What NAD+ actually is, why it does not get a purity certificate that looks like a peptide certificate, and what the literature supports
- Sourcing GuideTissue RepairImmune & Inflammation
KPV in Canada: The α-MSH Fragment in Inflammation Research
A tripeptide with a real preclinical literature, a July 2026 regulatory moment, and a supply market that has not caught up
- Sourcing GuideGrowth Hormone
Ipamorelin in Canada: The Selective Secretagogue
A pentapeptide whose defining property is what it does not do, and a certificate check that suits a small molecule
- Sourcing GuideGrowth Hormone
Tesamorelin in Canada: The GHRH Analogue With Approved-Drug Data
The only compound in the GH-axis catalogue with completed phase 3 trials, and why that does not transfer to a research vial
- Sourcing GuideMetabolic & GLP-1
Cagrilintide in Canada: The Long-Acting Amylin Analogue
The compound that made amylin the incretin field's second act, with published phase 2 data and no approval
- Sourcing GuideCognitive
Selank in Canada: The Tuftsin Analogue From the Russian Literature
A heptapeptide with a real research programme published almost entirely in one language, and what that means for reading the evidence
- Sourcing GuideLongevity
Epitalon in Canada: The Telomerase Claim, Examined
A four-residue peptide carrying one of the strongest claims in the field, and the thinnest independent evidence base to support it
- Sourcing GuideGrowth Hormone
Sermorelin in Canada: GHRH(1-29), and the Approval That Was Withdrawn
The shortest fully active GHRH fragment, once an approved diagnostic and paediatric agent, now a research material again
- Sourcing GuideImmune & Inflammation
Thymosin Alpha-1 in Canada: The Immune Peptide With Real Approvals Elsewhere
Approved in dozens of countries, never approved in North America, and sold here as a research material
- Sourcing GuideMetabolic & GLP-1Longevity
5-Amino-1MQ in Canada: The NNMT Inhibitor That Is Not a Peptide
A small molecule in a peptide catalogue, with a specific enzyme target and a certificate that should look different
- Sourcing GuideMetabolic & GLP-1
Eloralintide in Canada: The Selective Amylin Agonist
The newest compound on the metabolic shelf, with a short but genuinely peer-reviewed public record
Literature Overviews
2How These Articles Are Written
- 01Numbered inline citations tied to a References section with PMIDs or DOIs.
- 02A real batch-COA table where a compound is discussed — lot, HPLC purity, measured vs labelled content.
- 03Named human author with a public bio; published and updated dates shown.
- 04Regulatory statements link to the primary source and are dated.
- 05All content is for in vitro and laboratory research reference only. No dosing or administration guidance.
Editorial Team
Adam Reeves — Research Editor
Compiles compound overviews and COA methodology from peer-reviewed literature and Janoshik reports. Bio, credentials and contact on the author page.
All articles by Adam →New articles and batch results, weekly
One email. No promotions inside the research digest.
All products are supplied for in vitro and laboratory research purposes only.